Last reviewed · How we verify
Fibrin sealant hemipelvis
Fibrin sealant forms a hemostatic plug by cross-linking fibrin and thrombin to achieve rapid hemostasis at surgical sites.
Fibrin sealant forms a hemostatic plug by cross-linking fibrin and thrombin to achieve rapid hemostasis at surgical sites. Used for Hemostasis in hemipelvis surgical procedures.
At a glance
| Generic name | Fibrin sealant hemipelvis |
|---|---|
| Sponsor | IBON JAUNARENA |
| Drug class | Hemostatic agent / Fibrin sealant |
| Modality | Biologic |
| Therapeutic area | Surgery / Hemostasis |
| Phase | Phase 3 |
Mechanism of action
Fibrin sealant is a topical hemostatic agent composed of fibrinogen and thrombin that polymerizes at the wound site to create a stable fibrin clot. It is applied directly to bleeding surfaces during surgery to promote rapid hemostasis and reduce blood loss. The product is particularly used in hemipelvis procedures where achieving hemostasis in complex pelvic anatomy is challenging.
Approved indications
- Hemostasis in hemipelvis surgical procedures
Common side effects
- Infection at surgical site
- Hematoma formation
- Allergic reaction
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |